AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome

Al Sawah, Entidhar

437
AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

E. Al Sawah¹, Y. Xiong², B. Boac³, F. Abbasi², D. Marchion², I. Ramirez¹, S. H. Bush¹, C. McClung³, P. L. Judson Lancaster² and J. M. Lancaster²
¹University of South Florida College of Medicine, Tampa, FL, ²H. Lee Moffitt Cancer Center, Tampa, FL, ³H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

437
AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome

437 AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome

437
AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome